A federal program requiring manufacturers to sell outpatient drugs at discounted prices to qualifying safety-net providers.
340B-acquired drugs must be identified on claims with the appropriate modifier, and duplicate discounts — a 340B price plus a Medicaid rebate on the same unit — are prohibited.